As reported earlier, Prescrire had been sued by the manufacturer of tacrolimus ointment (Protopic®) on the grounds of “denigration” and claiming an “erroneous, or even deceitful, nature of certain critiques contained in the disputed article“.
The Tribunal de Grande Instance de Paris rejected the case stating that Prescrire “did not exceed the legitimate objective that it had set for itself, nor the expectation on the part of its subscribers to have access to a documented critical analysis on a subject which falls into the domain of public interest and healthcare safety“.
Prescrire note that this ruling supports the right to criticise provided that such criticism is supported by a rigorous and fully documented analysis.
Friday, March 11, 2011
Prescrire cleared by French court
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment